Cancer drug shows promise in reducing toxic genetic material in myotonic dystrophy
A group of researchers has shown for the first time in cells and in a mouse model that a drug used to treat cancer can neutralize the toxic RNA that causes the prolonged muscle contractions and other symptoms of myotonic ...
Dec 10, 2015
0
0